Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation

Elderly and frail patients with atrial fibrillation (AF) are at increased risk of thrombotic events, bleeding, and death compared to their counterparts, making their management challenging. With the introduction of non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) in the past decade, the ri...

Descripción completa

Detalles Bibliográficos
Autor principal: Giugliano, Robert P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Supplement Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850712/
https://www.ncbi.nlm.nih.gov/pubmed/35185404
http://dx.doi.org/10.1093/eurheartj/suab150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850712/
https://www.ncbi.nlm.nih.gov/pubmed/35185404
http://dx.doi.org/10.1093/eurheartj/suab150

Ejemplares similares